Clinical Trial Update: A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MK-6213 with statin atorvastatin in hypercholesterolemia completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• MK-6213 (MK-6213)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2018-11-01